With pioneering contributions in the field of cell therapy for cardiovascular diseases, Dr. Philippe Menasché is considered one of the most prestigious surgeons in the world. The researcher has been awarded several prizes such as the Lamonica of Cardiology laureates of the French Academy of Sciences and the Matmut for Medical Innovation, as well as the Earl Bakken Award for his scientific achievements.

His work has established him as a reference in the understanding of Heart Failure. In relation to this pathology, he stands out for having participated in the first intramyocardial transplant of autologous skeletal myoblasts, marking a true therapeutic milestone. He has also led clinical trials on the use of cardiac progenitors derived from human embryonic stem cells, as well as the application of tissue therapy combined with these progenitors in patients with terminal heart disease.

His research has also revealed the crucial role of paracrine signals in cardiac regeneration. As a result, his team has succeeded in developing cell therapy strategies based exclusively on the use of the secretome, with the aim of optimizing the clinical effectiveness and transmissibility of these procedures.

At the same time, this specialist maintains an active work as a surgeon at the European Hospital Georges Pompidou. In this institution, he also directs the Inserm 970 Unit. On the other hand, in the academic field, he is a professor in the Department of Biomedical Engineering at the University of Alabama at Birmingham, as well as at the University of Paris Descartes.

He holds a PhD in Medical Sciences from the Faculty of Paris-Orsay. He has also served as Director of the French National Institute of Health and Medical Research and, for almost two decades, he managed the Biosurgical Research Laboratory of the Carpentier Foundation.

• Director of the National Institute of Health and Medical Research (INSERM), Paris, France.
• Clinical Surgeon in the Heart Failure Unit of the European Hospital Georges Pompidou, Paris, France
• Regenerative Therapies for Heart and Vascular Diseases Team Leader
• Professor of Thoracic and Cardiovascular Surgery at the University Paris Descartes
• Academic Consultant to the Department of Biomedical Engineering at the University of Alabama at Birmingham
• Former Director of the Biosurgical Research Laboratory of the Carpentier Foundation
• Doctor of Medical Sciences from the Faculty of Paris-Orsay 
• Member of:  
  
  • National Council of Universities  
  • Medical and Scientific Council of the Agency for Biomedicine 
  • Working Group on Regenerative and Reparative Cardiovascular Medicine of the European Society of Cardiology